USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
19 Oct 2021 | Global
Global Orthopedics Growth Opportunities
Transformational Growth Driven by Digital Solutions is Shaping the Future of Orthopedics
The global orthopedic implant market is in the midst of a transformation. With enhanced research, product development is improving to suit patient requirements and support more successful surgical outcomes. The growth potential for orthopedic implants is more in emerging markets than in mature ones. This study provides revenue forecasts, market sha...
$4,950.00 -
12 Oct 2021 | North America
Global Structural Heart Devices Growth Opportunities
The Rise of Disruptive Technologies Driven by Increasing Competitive Intensity
A plethora of percutaneous treatment approaches has led to clinical care innovations in cardiac interventions. The past decade witnessed more applications of novel, catheter-based treatments for structural heart diseases. Many of these non-surgical, catheter-based interventional procedures have been proven effective, consequently resulting in great...
$4,950.00 -
08 Oct 2021 | North America
Global Tissue Diagnostics (TDx) Growth Opportunities
Companion Diagnostics (CDx)-specific Advanced Staining and Anatomical Pathology Laboratory Information Systems (APLIS) to Drive Ma
This research service provides an overview of the global TDx market and a 4-year forecast of it from 2021 to 2025. The market will reach $8,848.6 million in 2025, growing at a compound annual growth rate (CAGR) of 8.9% from 2020 to 2025. The advanced staining and anatomical pathology laboratory information management systems (APLIS) segments will g...
$4,950.00 -
06 Oct 2021 | North America
US Chronic Disease Management Growth Opportunities
Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management
The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches ...
$4,950.00 -
28 Sep 2021 | Global
Global Healthcare Cloud Growth Opportunities
Competitive Intensity Drives the Growth Potential of Hybrid and Multi-cloud Deployment Models
The COVID-19 pandemic has shown that many healthcare organizations do not have the necessary agility and business continuity programs or technologies to support them during crises. It is forcing businesses to act on cloud and digital transformation strategies that they had been delaying until now. The cloud is more critical than ever in helping...
$4,950.00 -
28 Sep 2021 | Global
Global Automated Endoscope Reprocessors (AER) Growth Opportunities
Breakthrough Technologies and Strategic Collaborations Drive Growth Strategies
While the entire healthcare industry adapts to changes induced by the COVID-19 pandemic, the endoscope reprocessing industry undergoes a major technology transformation. The rise in multiple infection outbreaks from contaminated endoscopes due to faulty endoscope reprocessing and manual errors in cleaning presents huge growth potential for automate...
$4,950.00 -
28 Sep 2021 | Global
Global Automated Endoscope Reprocessors (AER) Growth Opportunities
Breakthrough Technologies and Strategic Collaborations Drive Growth Strategies
While the entire healthcare industry adapts to changes induced by the COVID-19 pandemic, the endoscope reprocessing industry undergoes a major technology transformation. The rise in multiple infection outbreaks from contaminated endoscopes due to faulty endoscope reprocessing and manual errors in cleaning presents huge growth potential for automate...
$4,950.00 -
28 Sep 2021 | Global
Global Healthcare Cloud Growth Opportunities
Competitive Intensity Drives the Growth Potential of Hybrid and Multi-cloud Deployment Models
The COVID-19 pandemic has shown that many healthcare organizations do not have the necessary agility and business continuity programs or technologies to support them during crises. It is forcing businesses to act on cloud and digital transformation strategies that they had been delaying until now. The cloud is more critical than ever in helping...
$4,950.00 -
20 Sep 2021 | North America
Global In Vitro Diagnostics Market Outlook, 2021
Personalized Diagnostics and Increased Healthcare Investment to Drive Market Growth Post COVID-19 Pandemic
The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...
$4,950.00 -
13 Sep 2021 | North America
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential
This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of...
$4,950.00
